Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
Best Practice & Research. Clinical Haematology|February 18, 2018
Transformation of follicular lymphoma - Why does it happen and can it be prevented?Brian K Link
The Lancet. Haematology|November 4, 2018
Biosimilars: when a negative study can be positiveBrian K Link
Blood|June 5, 2020
Foreseeing what is to happen in DLBCLBrian K Link
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?Brian K Link
Haematologica|April 24, 2024
Follicular lymphoma treatment decisions: put GELF on the shelf?Brian K Link
Leukemia & Lymphoma|March 9, 2012
Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?Brian K Link
Journal of Oncology Practice|December 13, 2017
Early Relapse in Follicular Lymphoma: High Risks and High StakesBrian K Link
Clinical Pharmacology and Therapeutics|September 20, 2008
Imaging guiding therapy development in lymphomaB K Link
Leukemia & Lymphoma|September 18, 2008
The mysteries of mantle cell lymphoma--do PET scans provide a clue?Brian K Link
Oncology (Williston Park, N.Y.)|September 6, 2014
Identifying Appropriate Patient Groups and Drug Targets in DLBCLBrian K Link
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
Best Practice & Research. Clinical Haematology|February 18, 2018
Transformation of follicular lymphoma - Why does it happen and can it be prevented?Brian K Link
The Lancet. Haematology|November 4, 2018
Biosimilars: when a negative study can be positiveBrian K Link
Blood|June 5, 2020
Foreseeing what is to happen in DLBCLBrian K Link
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?Brian K Link
Haematologica|April 24, 2024
Follicular lymphoma treatment decisions: put GELF on the shelf?Brian K Link
Leukemia & Lymphoma|March 9, 2012
Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?Brian K Link
Journal of Oncology Practice|December 13, 2017
Early Relapse in Follicular Lymphoma: High Risks and High StakesBrian K Link
Clinical Pharmacology and Therapeutics|September 20, 2008
Imaging guiding therapy development in lymphomaB K Link
Leukemia & Lymphoma|September 18, 2008
The mysteries of mantle cell lymphoma--do PET scans provide a clue?Brian K Link
Oncology (Williston Park, N.Y.)|September 6, 2014
Identifying Appropriate Patient Groups and Drug Targets in DLBCLBrian K Link
Pageof 33